Skip to main content
. 2020 Dec 14;11(1):149–160. doi: 10.1007/s13555-020-00469-6

Fig. 2.

Fig. 2

Clinical response to dupilumab. a EASI & DLQI (median ± IQR) at baseline and 12–16 weeks (n = 156). b EASI & DLQI (median ± IQR) at baseline, 12–16 weeks and 26–30 weeks (n = 94)